𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Combined serotonin 5-HT2 and dopamine D2 receptor antagonism in the treatment of schizophrenia

✍ Scribed by Heylen, S.L.E.; Gelders, Y.G.

Book ID
123254035
Publisher
Elsevier Science
Year
1990
Tongue
English
Weight
158 KB
Volume
3
Category
Article
ISSN
0920-9964

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Combined serotonin-5-HT2 and dopamine-D2
Combined serotonin-5-HT2 and dopamine-D2 antagonism in schizophrenia: Clinical, extrapyramidal and neuroendocrine response in a preliminary study with risperidone (R 64 766)
✍ G. Bersani; G. M. Bressa; G. Meco; S. Marini; F. Pozzi πŸ“‚ Article πŸ“… 1990 πŸ› John Wiley and Sons 🌐 English βš– 580 KB

Previous studies suggested a therapeutic action of the selective serotonin 5-HT2-antagonist ritanserin on negative symptoms of schizophrenia and on neuroleptic-induced parkinsonism. In this open trial the effect of risperidone, a combined serotonin-5-HT2-and dopamine-D,-antagonist, was studied on a